Melanie Gartz

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Duchenne Muscular Dystrophy

Top Venues

Journal of cardiovascular pharmacology and therapeutics

Human molecular genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca A Slick, Jessica Sutton, Margaret Haberman, Benjamin S O'Brien, Jennifer A Tinklenberg, Aashay Mardikar, Mariah J Prom, Margaret Beatka, Melanie Gartz, Mark A Vanden Avond, Emily Siebers, David L Mack, J Patrick Gonzalez, Allison D Ebert, Kanneboyina Nagaraju, Michael W Lawlor
High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy. Biology open (2024)
Melanie Gartz, Margaret Haberman, Mariah J Prom, Margaret J Beatka, Jennifer L Strande, Michael W Lawlor
A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in mdx Mice. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Melanie Gartz, Margaret Beatka, Mariah J Prom, Jennifer L Strande, Michael W Lawlor
Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy. Human molecular genetics 30 (23) (2022)